PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21167292-7	2011	Selective inhibition of CYP2C9 decreased tumor cell proliferation (KYSE30, PT1590 and OE19) in vitro, which was abolished by 11,12-epoxyeicosatrienoic acid (11,12-EET).	11,12-epoxy-5,8,14-eicosatrienoic acid	125-155	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	24-30	
15652503-1	2005	Arachidonic acid is oxidized by cytochromes P450 2C (CYP2C) to epoxyeicosatrienoic acids (EETs), possessing vasoactive properties, with 11,12-EET as the endothelium derived hyperpolarization factor.	11,12-epoxy-5,8,14-eicosatrienoic acid	136-145	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	32-51	
15652503-1	2005	Arachidonic acid is oxidized by cytochromes P450 2C (CYP2C) to epoxyeicosatrienoic acids (EETs), possessing vasoactive properties, with 11,12-EET as the endothelium derived hyperpolarization factor.	11,12-epoxy-5,8,14-eicosatrienoic acid	136-145	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	53-58	
11867622-10	2002	Overexpression of CYP 2C9 significantly increased the expression of MKP-1, as did incubation with 11,12-EET.	11,12-epoxy-5,8,14-eicosatrienoic acid	98-107	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	18-25	
21167292-7	2011	Selective inhibition of CYP2C9 decreased tumor cell proliferation (KYSE30, PT1590 and OE19) in vitro, which was abolished by 11,12-epoxyeicosatrienoic acid (11,12-EET).	11,12-epoxy-5,8,14-eicosatrienoic acid	157-166	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	24-30	
19717402-9	2010	The prothrombotic effects of CYP2C9 inhibition in vivo were reversed by exogenous superfusion with 11,12-epoxyeicosatrienoic acids.	11,12-epoxy-5,8,14-eicosatrienoic acid	99-130	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	29-35